XML 31 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Shareholders' Equity and Noncontrolling Interest - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Vertex Shareholders’ Equity
Total Vertex Shareholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2017         253,253            
Balance at Dec. 31, 2017 $ 2,042,306 $ 9,229 $ 2,028,579 $ 9,229 $ 2,512 $ 7,157,362 $ (11,572) $ (24,120) $ (5,119,723) $ 33,349 $ 13,727
Increase (Decrease) in Stockholders' Equity                      
Other comprehensive (loss) income, net of tax 36,351   36,351       36,351        
Net income (loss) 2,087,103   2,096,896           2,096,896   (9,793)
Repurchases of common stock (in shares)         (2,094)            
Repurchases of common stock (350,043)   (350,043)   $ (21) (350,022)          
Issuance of common stock under benefit plans (in shares)         4,013            
Issuance of common stock under benefit plans 288,535   288,535   $ 55 288,480          
Stock-based compensation expense 325,656   325,656     325,656          
VIE noncontrolling interest upon deconsolidation (3,540)                   (3,540)
Other VIE activity (394)                   (394)
Ending balance (in shares) at Dec. 31, 2018         255,172            
Balance at Dec. 31, 2018 4,435,203 $ (40,310) 4,435,203 $ (40,310) $ 2,546 7,421,476 659 $ (24,120) (2,989,478) $ (40,310) 0
Increase (Decrease) in Stockholders' Equity                      
Other comprehensive (loss) income, net of tax (2,632)   (2,632)       (2,632)        
Net income (loss) 1,176,810   1,176,810           1,176,810    
Repurchases of common stock (in shares)         (1,046)            
Repurchases of common stock (186,020)   (186,020)   $ (10) (186,010)          
Common stock withheld for employee tax obligations (in shares)         (28)            
Common stock withheld for employee tax obligations (5,995)   (5,995)     (5,995)          
Issuance of common stock under benefit plans (in shares)         4,895            
Issuance of common stock under benefit plans 345,979   345,979   $ 53 345,926          
Stock-based compensation expense 362,209   362,209     362,209          
Ending balance (in shares) at Dec. 31, 2019         258,993            
Balance at Dec. 31, 2019 6,085,244   6,085,244   $ 2,589 7,937,606 (1,973)   (1,852,978)   0
Increase (Decrease) in Stockholders' Equity                      
Other comprehensive (loss) income, net of tax (66,507)   (66,507)       (66,507)        
Net income (loss) 2,711,647   2,711,647           2,711,647    
Repurchases of common stock (in shares)         (2,405)            
Repurchases of common stock (539,136)   (539,136)   $ (24) (539,112)          
Common stock withheld for employee tax obligations (in shares)         (804)            
Common stock withheld for employee tax obligations (200,271)   (200,271)   $ (8) (200,263)          
Issuance of common stock under benefit plans (in shares)         4,106            
Issuance of common stock under benefit plans 262,768   262,768   $ 42 262,726          
Stock-based compensation expense 433,070   433,070     433,070          
Ending balance (in shares) at Dec. 31, 2020         259,890            
Balance at Dec. 31, 2020 $ 8,686,815   $ 8,686,815   $ 2,599 $ 7,894,027 $ (68,480)   $ 858,669   $ 0